William Sandborn
Founder en Shoreline Biosciences, Inc. .
Fortuna: 399 207 $ al 31/03/2024
Perfil
William J.
Sandborn is the founder of Shoreline Biosciences, Inc. He currently holds positions as Director at Prometheus Laboratories, Inc., Chief-Gastroenterology & Professor-Clinical Medic at the University of California San Diego, and Advisor at Forbion Capital Partners Management Holding BV.
He formerly held the position of Director at Prometheus Biosciences, Inc. and President & Chief Medical Officer at Ventyx Biosciences, Inc. He received a doctorate degree from Loma Linda University in 1987 and an undergraduate degree from Southern University College.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
VENTYX BIOSCIENCES, INC.
0.12% | 31/08/2023 | 72 583 ( 0.12% ) | 399 207 $ | 31/03/2024 |
Cargos activos de William Sandborn
| Empresas | Cargo | Inicio |
|---|---|---|
| University of California San Diego | Corporate Officer/Principal | 01/01/2011 |
Prometheus Laboratories, Inc.
 Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | Director/Board Member | - |
Shoreline Biosciences, Inc.
 Shoreline Biosciences, Inc. BiotechnologyHealth Technology Shoreline Biosciences, Inc. engages in biotechnology business activities. The company is headquartered in La Jolla, CA. | Founder | - |
Forbion Capital Partners Management Holding BV
 Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Consultant / Advisor | - |
Antiguos cargos conocidos de William Sandborn.
| Empresas | Cargo | Fin |
|---|---|---|
| VENTYX BIOSCIENCES, INC. | President | 22/11/2023 |
| PROMETHEUS BIOSCIENCES, INC. | Director/Board Member | 04/02/2021 |
Formación de William Sandborn.
| Loma Linda University | Doctorate Degree |
| Southern University College | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| VENTYX BIOSCIENCES, INC. | Health Technology |
| Empresas privadas | 4 |
|---|---|
Prometheus Laboratories, Inc.
Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | Health Technology |
Forbion Capital Partners Management Holding BV
Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Finance |
Prometheus Biosciences, Inc.
 Prometheus Biosciences, Inc. BiotechnologyHealth Technology Prometheus Biosciences, Inc. engages in operation of a biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel precision therapeutics and companion diagnostics for patients living with unmet needs in gastroenterology and autoimmune diseases. The company was founded by Scott Glenn and Stephan Targan on October 26, 2016 and is headquartered in San Diego, CA . | Health Technology |
Shoreline Biosciences, Inc.
Shoreline Biosciences, Inc. BiotechnologyHealth Technology Shoreline Biosciences, Inc. engages in biotechnology business activities. The company is headquartered in La Jolla, CA. | Health Technology |
- Bolsa de valores
- Insiders
- William Sandborn
